BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Accumulated Expenses (2021 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Accumulated Expenses came in at $446507.0 in Q2 2026, up 22.69% on a YoY basis from $363922.0 in Q2 2025, and down 11.38% quarter-over-quarter from $503871.0 in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Accumulated Expenses (2021 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Accumulated Expenses for 6 consecutive years, with $446507.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses rose 22.69% year-over-year to $446507.0; the trailing twelve-month figure through Jun 2026 stood at $446507.0 (up 22.69% YoY), and the FY2025 full-year result was $503871.0, up 231.15% from the prior year.
  • Accumulated Expenses slipped to $446507.0 in Q2 2026 per BFRG's latest filing, from $503871.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $982988.0 in Q4 2022 and bottomed at $80694.0 in Q4 2023.
  • Historically, Accumulated Expenses has averaged $366128.4 across 5 years, with a median of $337407.5 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 1333.83% in 2022, then slumped 91.79% in 2023.
  • Over 5 years, Accumulated Expenses stood at $982988.0 in 2022, then plunged by 91.79% to $80694.0 in 2023, then surged by 88.56% to $152156.0 in 2024, then soared by 231.15% to $503871.0 in 2025, then retreated by 11.38% to $446507.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $446507.0, $503871.0, and $534883.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 446,507.00
Dec 31, 2025 503,871.00
Sep 30, 2025 534,883.00
Jun 30, 2025 363,922.00
Mar 31, 2025 464,794.00
Dec 31, 2024 152,156.00
Sep 30, 2024 515,658.00
Jun 30, 2024 268,437.00
Mar 31, 2024 182,834.00
Dec 31, 2023 80,694.00
Sep 30, 2023 122,257.00
Jun 30, 2023 195,903.00
Mar 31, 2023 310,893.00
Dec 31, 2022 982,988.00
Dec 31, 2021 68,557.00